Medscape November 4, 2025
Edited by Manasi Talwadekar

TOPLINE:

Opioid prescribing in US nursing homes decreased from 2011 to 2022, affecting residents across various levels of chronic pain. Minoritized residents were less likely to receive opioids or to have higher daily morphine milligram equivalents than White residents.

METHODOLOGY:

  • Researchers analyzed opioid prescribing patterns among nursing home residents using 100% Medicare fee-for-service data from 2011 to 2022.
  • Overall, 2.9 million unique long-stay nursing home residents (mean age, 84.2 years) in the United States were included.
  • Measured outcomes included the receipt of any opioid and daily morphine milligram equivalents greater than 50 over 90 days.
  • Race and ethnicity were identified using the Research Triangle Institute algorithm, and subgroup analyses were performed for residents with no, mild-to-moderate, or severe...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Post-Acute Care, Provider
Related Articles:
What Home-Based Care Consumers Really Want
M&Y Care LLC: The Main Differences Between Home Health Care and Non-Medical Home Care
Education, Care Coordination Move The Needle For Home-Based Care Consumers
Fighting Hospice Fraud an OIG Priority
Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Share Article